Advertisement

Lymphocyte shedding from genital tract of human immunodeficiency virus–infected women: Immunophenotypic and clinical correlates

      Abstract

      OBJECTIVE: Our purpose was to describe the lymphocyte subpopulations in genital tract samples from human immunodeficiency virus–infected women and the clinical correlates associated with lymphocyte shedding. STUDY DESIGN: Genital tract samples of women infected with human immunodeficiency virus-1 were processed for immunophenotyping analysis with a FACScan flow cytometer. Immunologic and virologic characteristics of women with and without lymphocyte shedding were compared with t test, Wilcoxon rank test, or Fisher's exact test. RESULTS: The rate of genital lymphocyte shedding among human immunodeficiency virus-1–infected women was 39%. Genital shedding was not related to age, race, use of antiretroviral therapy, or positive human immunodeficiency virus-1 culture. A negative rank correlation (r = −0.71, p = 0.047) between CD3+CD4+ counts in peripheral blood and genital tract was observed. The majority of the lymphocyte cells were CD3+CD8+, and >80% of the CD3+CD4+ cells were memory cells. CONCLUSION: The immune profile of the genital tract lymphocytes is suggestive of a local mucosal immune response. (Am J Obstet Gynecol 1997;176:158-65.)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. MMWR Morb Mortal Wkly Rep. 1993; 42: 481-486
      2. MMWR Morb Mortal Wkly Rep. 1995; 44: 81-84
        • Padian NS
        • Shiboski SC
        • Jewell NP
        The effect of number of exposures on the risk of heterosexual HIV transmission.
        J Infect Dis. 1990; 161: 883-887
        • Kreiss JK
        • Coombs R
        • Plummer F
        • et al.
        Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes.
        J Infect Dis. 1989; 160: 380-384
        • Anderson DJ
        • O'Brien TR
        • Politch JA
        • et al.
        Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type I in semen.
        JAMA. 1992; 267: 2769-2774
        • Padian NS
        • Shiboski SC
        • Jewell NP
        Female-to-male transmission of human immunodeficiency virus.
        JAMA. 1991; 266: 1664-1667
        • Vogt MW
        • Craven DE
        • Crawford DF
        • et al.
        Isolation of HTLV-III/LAC from cervical secretions of women at risk of AIDS.
        Lancet. 1986; 1: 525-527
        • Wofsy CB
        • Hauer LB
        • Michaelis BA
        • et al.
        Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus.
        Lancet. 1986; 1: 527-529
        • Clemetson DBA
        • Moss GB
        • Willerford DM
        • et al.
        Detection of HIV DNA in cervical and vaginal secretions: prevalence and correlates among women in Nairobi, Kenya.
        JAMA. 1993; 239: 2860-2864
        • Levy JA
        The transmission of AIDS: the case of the infected cell.
        JAMA. 1988; 259: 3037-3038
        • Kreiss J
        • Willerford DM
        • Hensel M
        • et al.
        Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA.
        J Infect Dis. 1994; 170: 1597-1601
        • Henin Y
        • Mandelbrot L
        • Henrion R
        • Pradinaud R
        • Coulaud JP
        • Montagnier L
        Virus excretion in the cervicovaginal secretions of pregnant and nonpregnancy HIV-infected women.
        J Acquir Immune Defic Syndr Hum Retrovirol. 1993; 6: 72-75
        • Pomerantz RJ
        • De la Monte SM
        • Donegan SP
        • et al.
        HIV infection of the uterine cervix.
        Ann Intern Med. 1988; 108: 321-327
        • Philip DM
        The role of cell-to-cell transmission in HIV infection.
        AIDS. 1994; 8: 719-731
        • Denny TN
        • Skurnick JH
        • Garcia A
        • et al.
        Lymphocyte immunoregulatory cells present in semen from HIV-infected individuals: a report from the HIV heterosexual transmission study.
        Comm Clin Cytom. 1996; 26: 47-51
        • Hill JA
        • Anderson DJ
        Human vaginal leukocytes and effects of vaginal fluid on lymphocyte and macrophage defense functions.
        Am J Obstet Gynecol. 1992; 166: 720-726
        • Calvelli T
        • Denny TN
        • Paxton H
        • Gelman R
        • Kagan JM
        Guidelines for flow cytometry immunophenotyping: a report from the National Institute of Allergy and Infectious Disease/Division of AIDS.
        J Cytom. 1993; 14: 702-715
        • AIDS Clinical Trial Group
        Virology manual for laboratories.
        National Institute of Allergy and Infectious Diseases, Division of AIDS, Bethesda (MD)1993
        • Vogt MW
        • Witt DJ
        • Craven DE
        • et al.
        Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndrome.
        Ann Intern Med. 1987; 106: 380-382
        • De Maria A
        • Pantaleo G
        • Schnittman ST
        • et al.
        Infection of CD8+ T lymphocytes with HIV: requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells.
        J Immunol. 1991; 146: 2220-2226
        • Sanders ME
        • Makgoba WM
        • Shaw S
        Human naive and memory T cells reinterpretation of helper-inducer and suppressor-inducer subsets.
        Immunol Today. 1988; 9: 195-199
        • Lehner T
        • Bergmeier LA
        • Panagiotidi C
        • et al.
        Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein.
        Science. 1992; 258: 1365-1369
        • Marx PA
        • Compans RW
        • Gettie A
        • Staas JK
        • Gilley RM
        • Mulligan MJ
        • et al.
        Protection against vaginal HIV transmission with microencapsulated vaccine.
        Science. 1993; 260: 1323-1327
        • Elias CJ
        • Heise L
        The development of microbicides: a new method of HIV prevention for women.
        Population Council, New York1993